Search

everythinglearnresearchcommunity

for

Search:↓

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

New hair loss treatments have evolved from understanding hair biology and patient needs.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

TGF-β and TNF influence hair follicle cell fate, with TNF being more effective in triggering cell death.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Testosterone helps human pancreatic cells increase insulin release.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Mice with human gene experienced hair loss when treated with DHT.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Finasteride works better for baldness in people with shorter gene repeats.

The method effectively measures drug impact on DHT levels in prostate treatments.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.